Display Settings:

Format

Send to:

Choose Destination
    J Med Chem. 2007 Jul 26;50(15):3420-2. Epub 2007 Jun 22.

    Imidazolylmethylbenzophenones as highly potent aromatase inhibitors.

    Abstract

    Suppression of tumor and plasma estrogen levels by inhibition of aromatase is one of the most effective treatments for postmenopausal breast cancer patients. Starting from an easy, synthetically accessible, benzophenone scaffold, a new class of potent aromatase inhibitors was synthesized, endowed with high selectivity with respect to 17 alpha-hydroxylase/17,20-lyase (CYP17). Compounds 1b and 1d proved to be among the most potent inhibitors described so far.

    PMID:
    17585752
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk